Cargando…

Metabolic Syndrome and Combination Antiretroviral Therapy in HIV Patients in Periurban Hospital in Ghana: A Case-Control Study

BACKGROUND: There is an increasing prevalence of cardiovascular diseases (CVDs) and risk factors in HIV patients as the levels of AIDS-related mortality and morbidity decrease. Metabolic syndrome (MetS) is the accumulation of various CVD risk factors that predict the occurrence of CVDs. We investiga...

Descripción completa

Detalles Bibliográficos
Autores principales: Dzudzor, Bartholomew, Essel, Samuel, Musah, Latif, Agyekum, Jennifer Adjepong, Yeboah, Kwame
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957619/
https://www.ncbi.nlm.nih.gov/pubmed/36846379
http://dx.doi.org/10.1155/2023/1566001
_version_ 1784894866341232640
author Dzudzor, Bartholomew
Essel, Samuel
Musah, Latif
Agyekum, Jennifer Adjepong
Yeboah, Kwame
author_facet Dzudzor, Bartholomew
Essel, Samuel
Musah, Latif
Agyekum, Jennifer Adjepong
Yeboah, Kwame
author_sort Dzudzor, Bartholomew
collection PubMed
description BACKGROUND: There is an increasing prevalence of cardiovascular diseases (CVDs) and risk factors in HIV patients as the levels of AIDS-related mortality and morbidity decrease. Metabolic syndrome (MetS) is the accumulation of various CVD risk factors that predict the occurrence of CVDs. We investigated the prevalence of MetS and associated risk factors in HIV patients treated with combination antiretroviral therapy (cART), cART-naïve HIV patients, and non-HIV controls. METHODS: In a case-control design, 158 cART-treated HIV patients, 150 cART-naïve HIV patients, and 156 non-HIV controls were recruited from a periurban hospital in Ghana. A structured questionnaire was used to collect data on demography, lifestyle, and medication. Anthropometric indices and blood pressure were measured. Fasting blood samples were collected to measure the plasma levels of glucose, lipid profile, and CD4+ cells. The presence of MetS was defined using the joint scientific statement criteria. RESULTS: The prevalence of MetS was higher in cART-treated HIV patients compared with cART-naïve HIV patients and non-HIV controls (57.3% vs. 23.6% vs. 19.2% and p < 0.001, respectively). MetS was associated with cART-treated HIV patients (odds ratio (95% CI) = 7.24 (3.41–15.39) and p < 0.001), cART-naïve HIV patients (2.04 (1.01–4.15), p=0.048), and female gender (2.42 (1.39–4.23) and p=0.002). In cART-treated HIV patients, those on zidovudine (AZT)-based regimens were associated with increased likelihood (3.95 (1.49–10.43) and p < 0.006), while those on tenofovir (TDF)-based had decreased likelihood (0.32 (0.13–0.8) and p=0.015) of having MetS. CONCLUSION: In our study population, there was a high prevalence of MetS in cART-treated HIV patients compared to cART-naïve HIV patients and non-HIV controls. HIV patients on AZT-based regimens had an increased likelihood of having MetS, while those on TDF-based regimens had a reduced likelihood of having MetS.
format Online
Article
Text
id pubmed-9957619
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-99576192023-02-25 Metabolic Syndrome and Combination Antiretroviral Therapy in HIV Patients in Periurban Hospital in Ghana: A Case-Control Study Dzudzor, Bartholomew Essel, Samuel Musah, Latif Agyekum, Jennifer Adjepong Yeboah, Kwame AIDS Res Treat Research Article BACKGROUND: There is an increasing prevalence of cardiovascular diseases (CVDs) and risk factors in HIV patients as the levels of AIDS-related mortality and morbidity decrease. Metabolic syndrome (MetS) is the accumulation of various CVD risk factors that predict the occurrence of CVDs. We investigated the prevalence of MetS and associated risk factors in HIV patients treated with combination antiretroviral therapy (cART), cART-naïve HIV patients, and non-HIV controls. METHODS: In a case-control design, 158 cART-treated HIV patients, 150 cART-naïve HIV patients, and 156 non-HIV controls were recruited from a periurban hospital in Ghana. A structured questionnaire was used to collect data on demography, lifestyle, and medication. Anthropometric indices and blood pressure were measured. Fasting blood samples were collected to measure the plasma levels of glucose, lipid profile, and CD4+ cells. The presence of MetS was defined using the joint scientific statement criteria. RESULTS: The prevalence of MetS was higher in cART-treated HIV patients compared with cART-naïve HIV patients and non-HIV controls (57.3% vs. 23.6% vs. 19.2% and p < 0.001, respectively). MetS was associated with cART-treated HIV patients (odds ratio (95% CI) = 7.24 (3.41–15.39) and p < 0.001), cART-naïve HIV patients (2.04 (1.01–4.15), p=0.048), and female gender (2.42 (1.39–4.23) and p=0.002). In cART-treated HIV patients, those on zidovudine (AZT)-based regimens were associated with increased likelihood (3.95 (1.49–10.43) and p < 0.006), while those on tenofovir (TDF)-based had decreased likelihood (0.32 (0.13–0.8) and p=0.015) of having MetS. CONCLUSION: In our study population, there was a high prevalence of MetS in cART-treated HIV patients compared to cART-naïve HIV patients and non-HIV controls. HIV patients on AZT-based regimens had an increased likelihood of having MetS, while those on TDF-based regimens had a reduced likelihood of having MetS. Hindawi 2023-02-17 /pmc/articles/PMC9957619/ /pubmed/36846379 http://dx.doi.org/10.1155/2023/1566001 Text en Copyright © 2023 Bartholomew Dzudzor et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Dzudzor, Bartholomew
Essel, Samuel
Musah, Latif
Agyekum, Jennifer Adjepong
Yeboah, Kwame
Metabolic Syndrome and Combination Antiretroviral Therapy in HIV Patients in Periurban Hospital in Ghana: A Case-Control Study
title Metabolic Syndrome and Combination Antiretroviral Therapy in HIV Patients in Periurban Hospital in Ghana: A Case-Control Study
title_full Metabolic Syndrome and Combination Antiretroviral Therapy in HIV Patients in Periurban Hospital in Ghana: A Case-Control Study
title_fullStr Metabolic Syndrome and Combination Antiretroviral Therapy in HIV Patients in Periurban Hospital in Ghana: A Case-Control Study
title_full_unstemmed Metabolic Syndrome and Combination Antiretroviral Therapy in HIV Patients in Periurban Hospital in Ghana: A Case-Control Study
title_short Metabolic Syndrome and Combination Antiretroviral Therapy in HIV Patients in Periurban Hospital in Ghana: A Case-Control Study
title_sort metabolic syndrome and combination antiretroviral therapy in hiv patients in periurban hospital in ghana: a case-control study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957619/
https://www.ncbi.nlm.nih.gov/pubmed/36846379
http://dx.doi.org/10.1155/2023/1566001
work_keys_str_mv AT dzudzorbartholomew metabolicsyndromeandcombinationantiretroviraltherapyinhivpatientsinperiurbanhospitalinghanaacasecontrolstudy
AT esselsamuel metabolicsyndromeandcombinationantiretroviraltherapyinhivpatientsinperiurbanhospitalinghanaacasecontrolstudy
AT musahlatif metabolicsyndromeandcombinationantiretroviraltherapyinhivpatientsinperiurbanhospitalinghanaacasecontrolstudy
AT agyekumjenniferadjepong metabolicsyndromeandcombinationantiretroviraltherapyinhivpatientsinperiurbanhospitalinghanaacasecontrolstudy
AT yeboahkwame metabolicsyndromeandcombinationantiretroviraltherapyinhivpatientsinperiurbanhospitalinghanaacasecontrolstudy